Tag Archives: BrainSignals_Series

Microsoft Copilot for Older Adults Warren and Merwin discussed the use of Microsoft Copilot, a tool that helps users create content and engage with AI through chat features. They explored how Copilot could assist older adults in accessing information and creating content from home, addressing concerns about digital dementia by …

“The first signal is not memory loss.It’s the breakdown of communication — and the stress it creates in the people who care.” This episode explains: Why BPSD is often more damaging than memory loss itself Why caregivers are untrained for emotional realism Why Validation Therapy matters neurologically Why LLMs embedded …

An aging brain is not simply a failing brain.It’s a changing brain Some of those changes are expected, natural adaptations over time.Others are the result of stressors we can actually modify — if we understand them.Let’s start with what we see clinically. In the clinic, when we follow people from …

Contains all episodes of the Alzheimer’s & Brain Health track. Why do I keep mentioning the window between seventy and eighty-three?Because that’s often when we see divergence.It’s the decade where “coasting” becomes risky.If we delay care until after the big decline shows itself, we lose valuable time.The cost of waiting …

Gene therapy approaches for Parkinson’s disease aim to modify or supplement gene expression to restore dopamine signaling, protect neurons, or modulate disease pathways. Recent advances show improved vector delivery, better safety profiles, and early signals of clinical benefit, though challenges remain around long-term efficacy, targeting, and scalability. Alzheimer’s & Neurodegeneration …

Warren Peters,  MD,  MPH,  FOMADirector – Metabolic Obesity Research Clinic (MORC)Associate Professor LOMA LINDA UNIVERSITY – School of Public Health From Dopamine Pills to Personalized Neurons: Aspen’s Autologous Cell Therapy for Parkinson’s Disease Parkinson’s disease (PD) has long been managed through pharmacology: levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and …